Press Releases

DDW Monumental Research Alerts

Be the first person to like this.
Digestive Disease Week® 2018 provides video highlights of several studies presented during the meeting. Listening to gut noises could improve diagnosis of irritable bowel syndrome What if doctors could diagnose a chronic gut condition by simply listening to the sounds the stomach makes as food passes through the body? A new study presented at Digestive Disease Week® (DDW) 2018 looks at how artificial intelligence can be used to create new ways to diagnose irritable bowel syndrome. What motivates people to donate their poop to medicine? As fecal microbiota transplant (FMT) is being used to treat an increasing number of digestive diseases and demand ...
Be the first person to like this.
Acoustic technology for listening to termites may offer less-invasive method to diagnose IBS   Washington, DC (June 5, 2018) — Utilizing newly adapted artificial intelligence, researchers have developed an acoustic belt that offers a new way to diagnose irritable bowel syndrome (IBS) by listening to the noises in a patient’s gut, according to research presented at Digestive Disease Week® (DDW) 2018 .   Study implications “IBS is an extremely common disorder that is notoriously difficult to diagnose. We wanted to find a way to listen to the rumblings and grumblings of the gut to identify patterns that characterize chronic gut conditions, ...
Be the first person to like this.
Demand for stool donors grows as benefits of fecal microbiota transplant are recognized   Washington, DC (June 5, 2018) — Appealing to a concern for others is the best way to recruit most people to donate their stool for medicine, while cash rewards may be an additional motivator for some potential donors, according to research scheduled for presentation at Digestive Disease Week® (DDW) 2018 .   Study implications “There’s an urgent medical need for stool donation, but many people have trouble getting over the ‘ick factor,’” said Breanna McSweeney, a medical student at University of Alberta, Canada, and lead author of the study. “Unfortunately, ...
Be the first person to like this.
Researchers have hope for immunotherapy approach that reinvigorates body’s natural defense against bowel cancer   Washington, DC (May 22, 2018) — For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer (CRC), potentially increasing life expectancy. Combining a DNA vaccine, which boosts the body’s immune response against tumors, with an antibody that blocks the body’s natural defense against the potency of the DNA vaccine, may lead to the development of an effective treatment for late stage CRC, when a cure is not often possible. Preliminary research leading up to this trial will be presented ...
Be the first person to like this.
Medical centers willing to perform transplants without mandated six-month wait Washington, DC (May 22, 2018) — Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018 . Study implications “Liver transplant for severe alcoholic hepatitis is being increasingly accepted, with positive outcomes, and the hope is that more and more patients will be evaluated for transplants,” said Saroja ...
Be the first person to like this.
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure Washington, DC (May 22, 2018) — An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet. Findings of the first phase 2 study of a biologic immune modulator in celiac disease will be presented at the upcoming Digestive Disease Week® (DDW) 2018 . Inadvertent exposure to gluten can be a frequent occurrence for celiac patients that triggers symptoms, such as pain in the gut and diarrhea, due to intestinal damage. Study implications ...
Be the first person to like this.
Oral-delayed release methylene blue aids in finding cancerous and pre-cancerous lesions Washington, D.C. (May 22, 2018) — Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC). When used in conjunction with colonoscopy, the blue dye increased adenoma detection rate (ADR) by nearly 9 percent, according to a study scheduled for presentation at Digestive Disease Week® (DDW) 2018 . Study implications Every year, nearly 137,000 people are diagnosed with CRC, and more than 50,000 people die from the disease. Yet, the disease is largely preventable with regular ...
Be the first person to like this.
WHAT:    A webinar media briefing with researchers to preview studies being presented at DDW ® 2018 in Washington, DC WHO:                Michael B. Wallace, MD, MPH, professor of medicine and a primary investigator on the Phase III Trial Francisco Leon, MD, PhD , former CEO/CMO of Celimmune, currently a consultant for Amgen Inc. Toan Pham, a PhD candidate and research fellow at the Peter MacCallum Cancer Centre at the University of Melbourne, Australia Saroja Bangaru, MD, chief resident in internal medicine at University of Texas Southwestern Medical Center, Dallas WHEN:     Monday, May 21; 10 – 11 a.m. EDT ...
Be the first person to like this.
Digestive Disease Week® 2018 — Media Registration Now Open Digestive Disease Week® (DDW) will host its annual scientific meeting in Washington, D.C., from June 2-5, 2018, bringing together physicians, researchers, and academics from across the world. Recognized as a top 50 medical meeting, this is your opportunity to learn cutting-edge medical advances and report on the latest research in gastroenterology, hepatology, endoscopy and gastrointestinal surgery. This year’s press program will offer reporters multiple opportunities to interact with leading researchers from the field. Pre-Conference Webinar : In May, before DDW 2018, Dr. Grace Elta, chair of ...
Be the first person to like this.
Bethesda, MD (June 26, 2017) — Highlighting the most relevant, up-to-date and cutting-edge science, Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, and 2017 saw a successful meeting. DDW is jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE), and the Society for Surgery of the Alimentary Tract (SSAT).  Recognized as a top 50 medical meeting, DDW 2017 ...
Be the first person to like this.
Researchers cite future role in improving acceptance, accuracy of colonoscopy Chicago, IL (May 8, 2017) — New research shows that an 18-mm magnetized capsule colonoscope, which can be paired with standard medical instruments, successfully performed intricate maneuvers inside the colon while guided by an external magnet attached to a robotic arm. Researchers believe this technology will reduce the potential discomfort of colonoscopies and lead to more people undergoing the life-saving screening test. This new study was presented at Digestive Disease Week® (DDW) 2017 , the largest international gathering of physicians, researchers and academics in ...
Be the first person to like this.
Study finds enzyme breaks down small amounts of gluten within the digestive system   Chicago, IL (May 7, 2017) — Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine. This could enable gluten-sensitive patients to ingest small quantities of gluten without experiencing symptoms, such as bloating, diarrhea and abdominal pain. The encouraging results from the enzyme known as aspergillus niger -derived prolyl endoprotease (AN-PEP) were presented at Digestive Disease Week® (DDW) 2017 , the largest international gathering of physicians, researchers ...
Be the first person to like this.
Less-invasive method also allows patients to return home on same day   Chicago, IL (May 7, 2017) — A new study finds that individuals struggling with obesity who are not candidates for weight-loss surgery can benefit substantially from non-surgical endoscopic sleeve gastroplasty, according to research presented at Digestive Disease Week® (DDW) 2017 , the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Patients who underwent ESG — a procedure performed through the mouth with an endoscope to “accordion” the stomach by suturing pleats ...
Be the first person to like this.
Researchers say carriers of a specific genotype could be evaluated earlier for liver transplants                                                     Chicago, IL (May 6, 2017) — Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants. This study was presented at Digestive Disease Week® (DDW) 2017 , the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. “Our findings ...
Be the first person to like this.
WHAT:    A webinar media briefing with researchers to preview studies being presented at Digestive Disease Week ® (DDW) 2017 in Chicago.   WHO:    Grace Elta, MD , chair, DDW Council               Winston Dunn, MD, associate professor, University of Kansas Medical Center, Kansas City               Reem Z. Sharaiha, MD, MSc , assistant professor, Weill Cornell Medical College, New York, NY               Keith Obstein, MD, MPH, associate professor, Vanderbilt University Medical Center, Nashville, TN               Julia König, PhD, post-doctoral research fellow, School of Medical Sciences at University of Örebro, ...
Be the first person to like this.
Media Registration Now Open Digestive Disease Week® (DDW) returns to Chicago, IL, from May 6-9, 2017, bringing together physicians, researchers and academics from across the world. Recognized as a top 50 medical meeting, this is your opportunity to learn cutting-edge medical advances and report on the latest research in gastroenterology, hepatology, endoscopy and gastrointestinal surgery. This year’s press program will offer reporters multiple opportunities to interact with leading researchers from the field. Pre-conference webinar : A week before DDW 2017, Dr. Grace Elta, chair of the DDW conference, will moderate a panel of experts ...
Be the first person to like this.
Bethesda, MD (March 1, 2017) — Digestive Disease Week® (DDW) is pleased to announce that our newly redesigned website, www.ddw.org , won an honorable mention award from AVA Digital, an international competition that recognizes outstanding work by creative professionals. DDW restructured the website to improve attendees’ experiences, by learning how attendees use the meeting website, and how it could better structured to meet their needs. As a result, several major changes were implemented: Mobile-First: In the past year alone, mobile traffic on org has grown more than 60 percent. The new site is completely mobile friendly ...
Be the first person to like this.
Bethesda, MD (Feb. 2, 2017) — As the largest international medical meeting dedicated to the science and practice of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, Digestive Disease Week (DDW®) occurs each year to facilitate the exchange of scientific knowledge and breakthroughs in digestive disorders. The leadership of DDW believes that the recent executive order banning travel of foreign nationals and refugees from seven countries to the U.S. will stifle discussion among members of the scientific community. Presentations and meetings that occur during DDW allow physicians and scientists from around the world to learn about ...
Be the first person to like this.
Jan. 9, 2017 — Digestive Disease Week® (DDW) is pleased to announce that DDW TV will be returning once again at DDW 2017 in Chicago, IL. DDW TV brings a different element to the conference using video and is a great platform to learn about best practices in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields. Partnering again with international film and broadcasting company WebsEdge, DDW TV will produce a new episode each day of the conference featuring: Conference News: On site, DDW TV will film expert interviews, capture session highlights, and hear delegates’ insights and reactions from around ...
Be the first person to like this.
Fecal microbiota transplantation relieves symptoms, heals the colon San Diego, CA (May 23, 2016) — Fecal microbiota transplantation (FMT) — a treatment currently used to address recurring Clostridium difficile infection — is also an effective approach to helping individuals who suffer from ulcerative colitis (UC), according to a study being presented at Digestive Disease Week® (DDW) 2016, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Researchers in Australia found that one in four patients who were resistant ...